124 related articles for article (PubMed ID: 38546190)
21. Changes in plasma catecholamine concentrations and haemodynamic effects of rocuronium and vecuronium in elderly patients.
Shorten GD; Uppington J; Comunale ME
Eur J Anaesthesiol; 1998 May; 15(3):335-41. PubMed ID: 9649995
[TBL] [Abstract][Full Text] [Related]
22. Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients.
Schramm WM; Strasser K; Bartunek A; Gilly H; Spiss CK
Br J Anaesth; 1996 Nov; 77(5):607-11. PubMed ID: 8957976
[TBL] [Abstract][Full Text] [Related]
23. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent.
Suy K; Morias K; Cammu G; Hans P; van Duijnhoven WG; Heeringa M; Demeyer I
Anesthesiology; 2007 Feb; 106(2):283-8. PubMed ID: 17264722
[TBL] [Abstract][Full Text] [Related]
24. Postoperative residual block after intermediate-acting neuromuscular blocking drugs.
Hayes AH; Mirakhur RK; Breslin DS; Reid JE; McCourt KC
Anaesthesia; 2001 Apr; 56(4):312-8. PubMed ID: 11284816
[TBL] [Abstract][Full Text] [Related]
25. Variability of duration of action of neuromuscular-blocking drugs in elderly patients.
Arain SR; Kern S; Ficke DJ; Ebert TJ
Acta Anaesthesiol Scand; 2005 Mar; 49(3):312-5. PubMed ID: 15752394
[TBL] [Abstract][Full Text] [Related]
26. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants.
Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C
Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of cyclodextrin (sugammadex) for reversal of intense neuromuscular block of rocuronium and vecuronium, experimental and clinical studies.
Alkenany HM
J Egypt Soc Parasitol; 2013 Dec; 43(3):705-14. PubMed ID: 24640870
[TBL] [Abstract][Full Text] [Related]
28. Rocuronium and vecuronium do not affect mandibular bone marrow and masseter muscular blood flow in rabbits.
Terakawa Y; Ichinohe T; Kaneko Y
J Oral Maxillofac Surg; 2010 Jan; 68(1):15-20. PubMed ID: 20006149
[TBL] [Abstract][Full Text] [Related]
29. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria.
Melnikov AL; Malakhov KY; Helgesen KG; Lathrop DA
Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069
[TBL] [Abstract][Full Text] [Related]
30. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
[TBL] [Abstract][Full Text] [Related]
31. Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial.
Horrow JC; Li W; Blobner M; Lombard J; Speek M; DeAngelis M; Herring WJ
BMC Anesthesiol; 2021 Feb; 21(1):62. PubMed ID: 33639839
[TBL] [Abstract][Full Text] [Related]
32. The agreement between adductor pollicis mechanomyogram and first dorsal interosseous electromyogram. A pharmacodynamic study of rocuronium and vecuronium.
Engbaek J; Roed J; Hangaard N; Viby-Mogensen J
Acta Anaesthesiol Scand; 1994 Nov; 38(8):869-78. PubMed ID: 7887113
[TBL] [Abstract][Full Text] [Related]
33. Priming studies with rocuronium and vecuronium.
Redai I; Feldman SA
Eur J Anaesthesiol Suppl; 1995 Sep; 11():11-3. PubMed ID: 8556997
[TBL] [Abstract][Full Text] [Related]
34. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
[TBL] [Abstract][Full Text] [Related]
36. The influence of cold on the recovery of three neuromuscular blocking agents in man.
England AJ; Wu X; Richards KM; Redai I; Feldman SA
Anaesthesia; 1996 Mar; 51(3):236-40. PubMed ID: 8712323
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic effects of rocuronium during fentanyl anaesthesia: comparison with vecuronium.
McCoy EP; Maddineni VR; Elliott P; Mirakhur RK; Carson IW; Cooper RA
Can J Anaesth; 1993 Aug; 40(8):703-8. PubMed ID: 8104727
[TBL] [Abstract][Full Text] [Related]
38. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children.
Bevan JC; Collins L; Fowler C; Kahwaji R; Rosen HD; Smith MF; de Scheepers LD; Stephenson CA; Bevan DR
Anesth Analg; 1999 Aug; 89(2):333-9. PubMed ID: 10439743
[TBL] [Abstract][Full Text] [Related]
39. Rocuronium versus vecuronium during fentanyl induction in patients undergoing coronary artery surgery.
Smith CE; Botero C; Holbrook C; Pinchak AC; Hagen JF
J Cardiothorac Vasc Anesth; 1999 Oct; 13(5):567-73. PubMed ID: 10527226
[TBL] [Abstract][Full Text] [Related]
40. Comparison of neuromuscular action of rocuronium, a new steroidal non-depolarizing agent, with vecuronium.
Lin PL; Liu CC; Fan SZ; Chao A; Shin SC; Tai YT
Acta Anaesthesiol Sin; 1997 Sep; 35(3):127-31. PubMed ID: 9407675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
